title: CXCR4 is dispensable for T cell egress from chronically inflamed skin via the afferent lymph.
abstract: T cell recirculation through extralymphoid tissues is essential to immune surveillance, host defense and inflammation. In this process, T cells enter the tissue from the blood and subsequently leave via the afferent lymph. In the absence of inflammation, T cells require CCR7 expression to egress from the skin or lung, which is consistent with the constitutive expression of the CCR7 ligand CCL21 on lymphatic endothelium. However, during chronic inflammation alternative chemoattractants come into play, allowing Ccr7-deficient (Ccr7-/-) T cells to egress efficiently from affected skin. As T cell egress from inflamed sites is a potential control point of the inflammatory response, we aimed to determine alternative T cell exit receptors using a mouse and a sheep model. We show that CCR7+ and CCR7- T cells exiting from the chronically inflamed skin were highly responsive to the CXCR4 ligand CXCL12, which was induced in the lymphatics in the inflamed site. Based on these findings, we hypothesized that CXCR4 mediates T cell egress from inflamed skin. However, pharmacological inhibition of CXCR4 did not affect the tissue egress of wildtype or Ccr7-/- CD4 and CD8 T cells after adoptive transfer into chronically inflamed skin. Similarly, adoptively transferred Cxcr4-/- Ccr7-/- and Ccr7-/- T cells egressed from the inflamed skin equally well. Based on these data, we conclude that, while CXCR4 might play an essential role for other cell types that enter the afferent lymphatics, it is dispensable for T cell egress from the chronically inflamed skin.
authors.affiliation: Department of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, Pennsylvania, United States of America.
authors.forename: Skye A
authors.initials: SA
authors.lastname: Geherin
authors.affiliation: Department of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, Pennsylvania, United States of America.
authors.forename: R Paul
authors.initials: RP
authors.lastname: Wilson
authors.affiliation: Department of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, Pennsylvania, United States of America.
authors.forename: Silke
authors.initials: S
authors.lastname: Jennrich
authors.affiliation: Department of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, Pennsylvania, United States of America.
authors.forename: Gudrun F
authors.initials: GF
authors.lastname: Debes
mesh_terms: D000818:Animals; D054377:Chemokine CXCL12 / Q000494:pharmacology; D002633:Chemotaxis / Q000187:drug effects; D002908:Chronic Disease; D006801:Humans; D007249:Inflammation / Q000276:immunology* / Q000473:pathology; D008196:Lymph / Q000187:drug effects / Q000276:immunology*; D008810:Mice, Inbred C57BL; D054400:Receptors, CCR7 / Q000172:deficiency / Q000378:metabolism; D019718:Receptors, CXCR4 / Q000037:antagonists & inhibitors / Q000172:deficiency / Q000378:metabolism*; D012756:Sheep; D012867:Skin / Q000473:pathology*; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology*
chemical_list: C514936:CXCR4 protein, mouse; C515371:Ccr7 protein, mouse; D054377:Chemokine CXCL12; D054400:Receptors, CCR7; D019718:Receptors, CXCR4
references.citation: J Immunol. 2000 May 15;164(10):5010-4
references.pmid: 10799853
references.citation: Proc Natl Acad Sci U S A. 1989 Sep;86(17):6734-8
references.pmid: 2528147
references.citation: Blood. 2011 Jul 7;118(1):205-15
references.pmid: 21596851
references.citation: BMC Immunol. 2004 Apr 26;5:7
references.pmid: 15109401
references.citation: J Immunol. 2006 Feb 15;176(4):2197-207
references.pmid: 16455976
references.citation: J Immunol. 2010 Nov 1;185(9):5130-9
references.pmid: 20889540
references.citation: Eur J Immunol. 2008 Nov;38(11):3050-9
references.pmid: 18924211
references.citation: J Immunol. 2012 Jun 15;188(12):6027-35
references.pmid: 22561151
references.citation: J Immunol. 2010 Oct 15;185(8):4873-82
references.pmid: 20833836
references.citation: J Immunol. 2012 Jan 15;188(2):578-84
references.pmid: 22156593
references.citation: J Virol. 2012 Apr;86(7):3436-45
references.pmid: 22278253
references.citation: J Immunol. 2006 Jan 1;176(1):557-66
references.pmid: 16365450
references.citation: Proteomics. 2012 Jun;12(12):1938-48
references.pmid: 22623068
references.citation: J Exp Med. 2006 Sep 4;203(9):2201-13
references.pmid: 16940167
references.citation: Nat Immunol. 2005 Sep;6(9):889-94
references.pmid: 16116468
references.citation: Vet Immunol Immunopathol. 2013 Sep 1;155(1-2):87-97
references.pmid: 23838472
references.citation: J Cell Sci. 2013 Nov 15;126(Pt 22):5259-70
references.pmid: 24006262
references.citation: Science. 1993 Jul 30;261(5121):600-3
references.pmid: 8342023
references.citation: Mol Pharmacol. 2009 May;75(5):1240-7
references.pmid: 19255243
references.citation: Cell. 1999 Oct 1;99(1):23-33
references.pmid: 10520991
references.citation: J Immunol. 2013 Feb 1;190(3):970-6
references.pmid: 23255361
references.citation: J Immunol. 2005 Feb 1;174(3):1693-700
references.pmid: 15661933
references.citation: Nat Immunol. 2013 Dec;14(12):1285-93
references.pmid: 24162775
references.citation: J Immunol. 2009 Feb 1;182(3):1287-95
references.pmid: 19155474
references.citation: J Exp Med. 2003 Aug 18;198(4):615-21
references.pmid: 12925677
references.citation: Eur J Immunol. 2013 Jun;43(6):1430-5
references.pmid: 23580465
references.citation: Immunity. 1999 Apr;10(4):463-71
references.pmid: 10229189
references.citation: Nat Immunol. 2005 Sep;6(9):895-901
references.pmid: 16116469
references.citation: Am J Pathol. 2007 Oct;171(4):1249-57
references.pmid: 17823289
references.citation: J Leukoc Biol. 2010 Apr;87(4):671-82
references.pmid: 20028772
references.citation: J Exp Med. 2005 Apr 18;201(8):1307-18
references.pmid: 15837815
references.citation: Nature. 1998 Jun 11;393(6685):591-4
references.pmid: 9634237
references.citation: Nat Immunol. 2001 Feb;2(2):129-34
references.pmid: 11175805
references.citation: PLoS One. 2010 Feb 11;5(2):e9175
references.pmid: 20161793
references.citation: Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2305-9
references.pmid: 8134392
references.citation: Nature. 1998 Jun 11;393(6685):595-9
references.pmid: 9634238
references.citation: J Exp Med. 1997 Oct 20;186(8):1389-93
references.pmid: 9334379
references.citation: Nature. 1996 Aug 15;382(6592):635-8
references.pmid: 8757135
references.citation: J Immunol. 1999 Mar 1;162(5):2472-5
references.pmid: 10072485
references.citation: Q J Exp Physiol Cogn Med Sci. 1961 Jul;46:199-205
references.pmid: 13759245
references.citation: J Immunol. 2001 Sep 15;167(6):3064-73
references.pmid: 11544290
references.citation: Blood. 2007 Feb 1;109(3):886-95
references.pmid: 17018859
references.citation: J Exp Med. 2004 Apr 19;199(8):1113-20
references.pmid: 15096537
references.citation: J Invest Dermatol. 2006 Feb;126(2):468-76
references.pmid: 16385346
references.citation: J Med Chem. 1995 Jan 20;38(2):366-78
references.pmid: 7830280
references.citation: Nat Immunol. 2013 Dec;14(12):1294-301
references.pmid: 24162776
references.citation: J Immunol. 2001 Oct 15;167(8):4686-92
references.pmid: 11591799
references.citation: Pharmacol Rev. 2013 Nov 11;66(1):1-79
references.pmid: 24218476
references.citation: Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9448-53
references.pmid: 9689100
references.citation: J Exp Med. 1990 Mar 1;171(3):801-17
references.pmid: 2307933
references.citation: J Biol Chem. 2005 Oct 21;280(42):35760-6
references.pmid: 16107333
references.citation: Proc Natl Acad Sci U S A. 1998 Jan 6;95(1):258-63
references.pmid: 9419363